Now I have a thorough understanding of the paper and can verify each claim against the actual text. Let me write the consolidated review.

---

## Summary

This paper proposes SE3Set, an SE(3)-equivariant hypergraph neural network for molecular representation learning. The key innovations are: (1) a fragmentation method that constructs hyperedges by fusing 2D chemical information (bond orders, functional groups, rings) with 3D spatial proximity, and (2) equivariant vertex-to-edge (V2E) and edge-to-vertex (E2V) attention blocks built on the AllSet framework and Equiformer. The method achieves results on par with SOTA on QM9 (12 tasks) and demonstrates consistent ~20% MAE improvement on 5 of 7 MD22 molecule types for both energy and force prediction.

---

## Strengths

1. **Fragmentation method jointly leveraging 2D chemistry and 3D geometry.** Section 4.1 defines a principled 4-step algorithm that masks high-order bonds and ring/functional-group atoms, applies BFS to identify core substructures, aggregates them with a minimum-atom-count rule, and expands fragments using either explicit spatial overlap (cutoff \(c_w\)) or implicit overlap (radial cutoff \(r_c\)). This is the first hypergraph construction for molecules that systematically integrates bond orders, SMARTS-identified substructures, and 3D distances, going beyond prior fragmentation methods that neglect spatial data (Sec. 2.3).

2. **Consistent ~20% MAE reduction on MD22 across five molecule types.** Table 2 reports energy and force MAEs for Ac-Ala3-NHMe, DHA, Stachyose, AT-AT, and AT-AT-CG-CG, with SE3Set outperforming the previous best model (ViSNet-LSRM) by 11.7%–27.8% in energy and 19.1%–28.9% in forces. For example, Stachyose energy MAE drops from 0.1055 to 0.0762 (27.8%) and force MAE from 0.0767 to 0.0424 (21.9%). This systematic improvement across diverse biomolecules provides evidence that encoding many-body interactions via equivariant hypergraphs yields tangible accuracy gains where higher-order effects dominate.

3. **Equivariant V2E and E2V attention design with geometric tensor products.** The V2E attention (Eqs. 1–4) uses spherical harmonics and distance-weighted depth-wise tensor products to maintain SE(3) equivariance, and the E2V attention (Eqs. 7–15) aggregates hyperedge features through tensor products with node features. The paper also compares two E2V variants (tensor-product vs. summation) and reports that the tensor-product version is superior (Sec. 5.3). This design is distinct from prior equivariant HGNNs that handle only node permutations, not 3D rotations (Sec. 2.2).

---

## Weaknesses

### Fatal

None.

### Major

1. **MD17 evaluation claimed but not presented.** The abstract states that "SE3Set has shown performance on par with state-of-the-art (SOTA) models for small molecule datasets like QM9 and MD17." The introduction (item 4) and the Results section header (line 174) repeat the same commitment: "QM9 and MD17 gauge small molecule property prediction." Yet no MD17 results—no table, no figure, no text—appear anywhere in the paper. The only experimental results shown are on QM9 (Table 1) and MD22 (Table 2). This is not a minor omission: the paper explicitly promises evaluation on MD17 to support its "on par with SOTA" claim for small molecules, but the evidence is absent. The reader cannot verify whether the method works on this standard benchmark.

2. **Ablation study lacks any quantitative results.** Section 5.3 (lines 251–253) describes ablation experiments on fragmentation method (varying \(c_w\), comparing to BRICS), E2V architecture variants, and layer depth, but provides **zero numerical values**. The text states "As Fig.~\ref{fig:ablation} indicates" with a reference to an embedded figure, but no numeric data is reported in the prose. The reader cannot evaluate whether the fragmentation method is the source of improvement, how much better the tensor-product E2V variant is, or the magnitude of gain from 3 to 6 layers. For a new method whose primary novelty is hypergraph construction + equivariant architecture, quantitative ablation evidence is essential to isolate each contribution. The current presentation is essentially a qualitative summary.

3. **Selective exclusion of 2 of 7 MD22 molecules without justification.** The paper states (line 243): "Our fragmentation method, which maintains functional groups and rings, selectively excludes structures like the Buckyball catcher and Double-walled nanotube from MD22, thus concentrating on the other five molecular types." No explanation is given for why these molecules are excluded—whether the fragmentation method *cannot handle* them (a structural limitation of the approach) or whether they were omitted for convenience (incomplete evaluation). If the method has fundamental difficulty with certain molecular topologies, this should be discussed as a limitation. If they can be handled, results should be reported. Either way, the paper's claim of "approximately 20% in accuracy across all molecules" in the abstract refers only to a curated subset, which is not "all molecules" in the dataset.

### Minor

1. **No statistical uncertainty reported.** All results tables (Tables 1–2) report single MAE values with no standard deviations, confidence intervals, or number of seeds. On QM9, many values are very close (e.g., 0.011 vs 0.011 vs 0.010 for \(\mu\)), and on MD22, some improvements are modest (DHA energy: 5.4%; AT-AT-CG-CG energy: 11.7%). Without error bars, the reader cannot assess whether these differences are meaningful across runs. While single-run reporting is common in this subfield, it weakens the experimental contribution.

2. **QM9 \(R^2\) performance substantially undermines the "on par" framing.** The paper claims SE3Set is "on par with SOTA" for small molecules. On most QM9 tasks this is reasonable, but on \(R^2\) SE3Set achieves 0.197 \(a_0^2\) vs. the best model (ViSNet at 0.030)—a factor of ~6.5x worse. The gap is large enough that "on par" is misleading for this task. While the paper acknowledges that "higher-order many-body interactions are less pronounced" in small molecules and that "SE3Set does not significantly outperform" SOTA models, the framing in the abstract and introduction should be more precise.

### Trivial

- None.

---

## Nice-to-Haves

- **Computational cost analysis.** The paper motivates the implicit overlap method (step 4*) as "more computationally efficient" and states that controlling fragment size "balance[s] capturing meaningful interactions and computational efficiency," but provides no runtime, memory usage, or scaling comparison. Adding wall-clock time and memory measurements would strengthen the practical contribution.
- **Training hyperparameters.** No learning rate, optimizer, batch size, or number of epochs are reported. Adding these would improve reproducibility.
- **Equivariance walk-through.** While the architecture builds on Equiformer (which is proven equivariant), a brief note on why each operation preserves equivariance (e.g., attention weights from \(l=0\) features, tensor-product structure) would be helpful for reader confidence.

---

## Removed Points

*These points are flagged to be removed; treat them with caution.*

- **Missing training hyperparameters (REMOVED per rule: "REMOVE nitpicks about reproducibility such as undisclosed hyperparameters").** The reviewer's point is technically correct (no learning rate, optimizer, etc. reported), but the rule directs removal on the grounds that these are reproducibility nitpicks. Moved to Nice-to-Haves above.
- **Missing computational cost analysis (REMOVED — broad demand not fulfilling a specific claim in the paper; the paper does not promise runtime benchmarks).** Moved to Nice-to-Haves above.
- **Equivariance proof concern (REMOVED — the paper explicitly builds on Equiformer [line 66: "built on the Equiformer"], which is a published and peer-reviewed architecture with proven SE(3) equivariance. The V2E/E2V operations use standard tensor products with \(l=0\) attention weights and spherical harmonics, following established patterns. The criticism demands a level of proof not standard for architecture papers that build on proven foundations.)**
- **Baseline comparison fairness for MD22 (REMOVED — the paper transparently notes baseline sources: "The results of TorchMD-Net, Allegro, and Equiformer are extracted from Ref. [li2024longshortrange]." This is standard practice. The missing models (MACE-OFF, NequIP) are not universally expected; the comparison against 8 baselines with the cited reference is reasonable.)**
- **Strength about ablation showing fragmentation superiority (REMOVED per rule: "Drop strengths that conflict with a verified weakness — when a strength and weakness disagree, the weakness wins." The ablation weakness (no numbers) means this claimed strength is not actually supported by evidence in the paper.)**
- **Missing related works (REMOVED per rule: "DO NOT mention missing related works, as you do not have external sources to confirm their existence.")**
- **Formatting/typography/grammar nitpicks (REMOVED per rule: parser artifacts + formatting nitpicks are not author errors.)**

---

## Novel Insights

None beyond the paper's own contributions. The reviews do not surface a perspective on the paper that the authors themselves do not already articulate.

---

## Suggestions

1. **Add the missing MD17 results.** This is the single most important addition. Include a table or text reporting energy/force MAEs and compare them against the baselines in Table 1 to substantiate the "on par with SOTA" claim.
2. **Replace the qualitative ablation with a quantitative table.** Report MAE values for: (a) no fragmentation (standard graph), (b) BRICS fragmentation, (c) proposed fragmentation with varying \(c_w\), (d) both E2V variants (tensor product vs. summation), and (e) 3 vs. 6 layers. This is the most impactful single addition for establishing causality.
3. **Either justify or address the excluded MD22 molecules.** Report results on the full MD22 dataset, or add a clear experimental section explaining why the fragmentation method cannot handle Buckyball catcher and Double-walled nanotube, and temper the abstract's "all molecules" claim to "5 of 7 molecule types."
4. **Report error bars (3+ seeds).** Add standard deviations to Tables 1 and 2 to establish robustness of the reported improvements.
5. **Add a brief limitations section** to the conclusion acknowledging the selective MD22 exclusion, the lack of uncertainty quantification, and the \(R^2\) gap on QM9.

---

## Score and Decision

MY FINAL SCORE: <score>4.5</score>
MY FINAL DECISION: <decision>Reject</decision>